These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1980216)

  • 1. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation.
    Goldman R; Levy RB; Peles E; Yarden Y
    Biochemistry; 1990 Dec; 29(50):11024-8. PubMed ID: 1980216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterodimerization of c-erbB2 with different epidermal growth factor receptor mutants elicits stimulatory or inhibitory responses.
    Spivak-Kroizman T; Rotin D; Pinchasi D; Ullrich A; Schlessinger J; Lax I
    J Biol Chem; 1992 Apr; 267(12):8056-63. PubMed ID: 1349015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidermal growth factor receptor and the product of the neu protooncogene are members of a receptor tyrosine phosphorylation cascade.
    Connelly PA; Stern DF
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6054-7. PubMed ID: 1974718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases.
    Quian XL; Decker SJ; Greene MI
    Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1330-4. PubMed ID: 1346931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4.
    Chen X; Levkowitz G; Tzahar E; Karunagaran D; Lavi S; Ben-Baruch N; Leitner O; Ratzkin BJ; Bacus SS; Yarden Y
    J Biol Chem; 1996 Mar; 271(13):7620-9. PubMed ID: 8631797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
    Stern DF; Heffernan PA; Weinberg RA
    Mol Cell Biol; 1986 May; 6(5):1729-40. PubMed ID: 2878363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function.
    Wada T; Qian XL; Greene MI
    Cell; 1990 Jun; 61(7):1339-47. PubMed ID: 1973074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3.
    King CR; Borrello I; Bellot F; Comoglio P; Schlessinger J
    EMBO J; 1988 Jun; 7(6):1647-51. PubMed ID: 2901952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation.
    Qian X; LeVea CM; Freeman JK; Dougall WC; Greene MI
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1500-4. PubMed ID: 7509075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.
    Pinkas-Kramarski R; Lenferink AE; Bacus SS; Lyass L; van de Poll ML; Klapper LN; Tzahar E; Sela M; van Zoelen EJ; Yarden Y
    Oncogene; 1998 Mar; 16(10):1249-58. PubMed ID: 9546426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions.
    Stern DF; Kamps MP
    EMBO J; 1988 Apr; 7(4):995-1001. PubMed ID: 3261240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structurally related class I and class II receptor protein tyrosine kinases are down-regulated by the same E3 protein coded for by human group C adenoviruses.
    Kuivinen E; Hoffman BL; Hoffman PA; Carlin CR
    J Cell Biol; 1993 Mar; 120(5):1271-9. PubMed ID: 8094718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.
    Komurasaki T; Toyoda H; Uchida D; Morimoto S
    Oncogene; 1997 Dec; 15(23):2841-8. PubMed ID: 9419975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy.
    Stancovski I; Peles E; Ben Levy R; Lemprecht R; Kelman Z; Goldman-Michael R; Hurwitz E; Bacus S; Sela M; Yarden Y
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):95-103. PubMed ID: 1356018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses.
    Lupu R; Colomer R; Kannan B; Lippman ME
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2287-91. PubMed ID: 1347947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
    Ben-Levy R; Peles E; Goldman-Michael R; Yarden Y
    J Biol Chem; 1992 Aug; 267(24):17304-13. PubMed ID: 1355090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
    Liu SM; Carpenter G
    J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of cellular platelet-derived growth factor receptors induced by an activated neu receptor tyrosine kinase.
    Lehtola L; Nistér M; Hölttä E; Westermark B; Alitalo K
    Cell Regul; 1991 Aug; 2(8):651-61. PubMed ID: 1685673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.